How to Prevent Hospital Readmissions: What the Evidence Supports

Discharge planning, medication reconciliation, patient education and targeted follow-up: what the trial evidence says, and how to build it into a service.

Readmissions fall when the weeks after discharge are managed as part of treatment, not as an afterthought. The strongest trial evidence points to structured discharge planning, medication reconciliation, patient education and timely, targeted follow-up. This article sets out the evidence for each element so you can judge what to build into your own service, and where a blended-care platform can help a team organise the time between contacts.

Key takeaways

  • Patient- and family-centred transition interventions cut readmission risk by about 14% against usual care in a meta-analysis of randomised trials, and the more patient-centred components an intervention had, the larger the effect.
  • Medication reconciliation and patient education are the most consistently supported tools: each extra component in a programme was linked to a further fall in readmissions.
  • Follow-up works best when it is targeted. Outpatient review within 30 days helped most for patients aged 65+ with heart failure, heart attack, stroke or COPD.
  • Support that bridges the whole transition, with self-management, telephone contact and medicines review, did better than a single hand-off.
  • Digital tools can help a team deliver education and stay in contact after discharge. Clinical review and decisions stay with the care team.

Table of contents

What counts as a readmission, and why the definition matters

A readmission is an unplanned return to hospital shortly after discharge. The usual window is 30 days, although some English studies use 28. In England, NHS Digital's indicator measures the percentage of emergency admissions to any hospital within 30 days of the previous discharge, so a return to a different hospital still counts.

In the United States, the Centers for Medicare & Medicaid Services use an all-cause definition: any hospital, any reason, with separate measures for heart attack, heart failure, pneumonia, COPD and some procedures. Since 2014 planned admissions such as a scheduled angioplasty have been excluded from the count. The US rule is tied to payment, which is why it features so heavily in the literature. In a UK or Swiss service the question is simpler: which of your patients came back, and could a different first week at home have prevented it?

The scale is real. A UK discharge follow-up study reports that NHS trusts recorded 529,318 emergency readmissions in 2016/17, up almost 25% over four years, and that 15% of people over 65 in England were readmitted within 28 days. The same paper notes there is no consensus on how many are avoidable. One review it cites found a median of 27.1% avoidable, with studies ranging from 5% to 79%. That is the reason to aim interventions at the people and causes where the evidence is strongest, not at everyone.

Why patients come back

The causes cluster around the transition itself, not the original diagnosis alone:

  • Medication problems. Changed doses, new prescriptions and unclear instructions create discrepancies between what the hospital intended and what the patient takes.
  • Gaps in understanding. Patients leave without being sure which symptoms are expected and which mean they need help.
  • Weak hand-offs. Information does not reach the GP, community team or carer in time.
  • Unmet behavioural health and social needs. The US Agency for Healthcare Research and Quality describes these as key risk factors for adverse events after discharge.

Each of these maps to an intervention with trial evidence behind it.

What the evidence says works

Three large syntheses give a consistent picture.

A 2025 umbrella review of 34 systematic reviews identified 20 types of discharge-planning intervention in six categories. Patient education was the most studied. The evidence was rated high for reduced readmissions, fewer medication discrepancies and greater patient satisfaction. The authors also call for more tailored strategies, because effects varied between populations and intervention types.

A 2023 meta-analysis of randomised trials found that patient- and family-centred transition interventions lowered readmission risk against usual care (incident rate ratio 0.86; 95% CI 0.75 to 0.98). Interventions with more patient-centred components did better (0.73), as did those with more care-transition components (0.76).

A 2025 review of discharge planning for stroke and heart conditions, covering 16 studies in 11 countries, found most interventions had positive short-term effects. Benefits were clearest when the approach was multidisciplinary, nurse-led or digitally supported, including text messages, phone calls and interactive voice response.

The practical reading is that no single tool does the work. Programmes with several coordinated components, centred on what the patient understands and can do, perform best.

Medication reconciliation and patient education

If you build only one thing, build this. Medication reconciliation means comparing what a patient was taking before admission with what they are prescribed at discharge, and resolving the differences.

A BMJ Quality & Safety meta-analysis of 14 studies and 8,182 patients found that medication-related interventions delivered in hospital and after discharge reduced 30-day all-cause readmissions by 3.8 percentage points (RR 0.79; 95% CI 0.65 to 0.96; number needed to treat 27). Each additional intervention component was associated with a further 17% fall in the readmission rate.

A review of 24 trials in 17,664 participants, mostly aged 65 or over, looked at which parts of a programme mattered. Interventions that bridged the transition for up to 90 days were most effective. Within them, self-management activities (RR 0.81), telephone follow-up (RR 0.84) and medication reconciliation (RR 0.88) were each linked to fewer readmissions.

Two lessons follow. First, the effect builds with layers: education plus reconciliation plus follow-up beats any one alone. Second, the support has to last past the first few days. Medicines questions often arise in week two or three, when no one from the hospital is in touch.

Follow-up: make it timely and make it targeted

Follow-up after discharge is the intervention most often prescribed and the hardest to resource. A 2025 meta-analysis of 83 studies found that outpatient follow-up within 30 days was associated with lower 30-day readmission risk (relative risk ratio 0.68; 95% CI 0.60 to 0.75). In the better-quality studies, the benefit was concentrated in patients aged 65+ with heart failure (0.65), acute myocardial infarction (0.56), stroke or COPD (0.73). Follow-up within 7 to 14 days reduced readmissions only in the 65+ group with heart failure or heart attack.

The authors' conclusion is useful for planning. Universal follow-up is not feasible, so the question is for whom and when. A simple triage, decided by the care team:

Patient groupSuggested approach
Aged 65+ with heart failure, heart attack, stroke or COPDEarly clinical follow-up plus ongoing contact and education
Complex medicines changesReconciliation at discharge, then a structured check-in by the care team during the first weeks
Mental health inpatientsWritten hand-over within days and a scheduled follow-up
Lower-risk patientsLighter-touch contact with a clear route back to the team

For mental health, a 2018 review in The British Journal of Psychiatry covering 15 studies on early readmission found absolute risk reductions of 13.6% to 37.0% in the studies with significant results. The effective components included psychoeducation before and after discharge, structured needs assessment, medication education, transition managers and communication between inpatient and outpatient providers.

Coordination between hospital, community and home

UK guidance is clear on timing. NICE guideline NG27 recommends that hospital and community multidisciplinary teams work together from admission, or earlier where possible, to identify and address anything that could stop a safe, timely transfer of care.

For mental health inpatient care, NICE guideline NG53 sets out specific timings: a discharge letter emailed to the GP within 24 hours, the latest care plan sent to everyone involved within 24 hours, a discharge summary within a week, and a GP follow-up appointment considered within two weeks, with written details given to the person.

AHRQ adds a point about the patient's experience. It argues that primary care teams should reach in during the hospital stay, speaking to the patient and family so they know their team is involved and expect timely follow-up. That applies equally to a hospital outpatient clinic, a rehabilitation service or a community mental health team.

Where blended care fits

The evidence above describes what to do. The harder question is how a team does it for every patient without more staff time. Blended care combines in-person contact with digital tools the patient uses between visits, while the clinical work stays with the team.

Some elements of the evidence translate well into a digital format:

  • Patient education and self-management: the professional puts together education material, exercises and multimedia content, and the patient works through it at home at their own pace.
  • Content that fits the patient: a patient after cardiac surgery and a patient in post-operative rehabilitation do not need the same material, so the professional chooses what each person receives.
  • Rehabilitation: exercise programmes can continue at home, as described on our rehabilitation and recovery page.
  • Staying in touch: the patient has a clear channel to the team between contacts. Assessment, medicines review and clinical decisions remain with the professionals.

The digital layer works best alongside human contact, not instead of it. The 2025 review on stroke and heart conditions found benefits when discharge planning was multidisciplinary, nurse-led or digitally supported, and a 2025 Colombian study of 278 patients also pointed to hybrid, patient-centred communication that keeps phone contact in the mix. That is the blended model: in-person care, clinician-led contact and digital support working together. You can read more on how blended care works.

A practical readmission-prevention pathway

Here is a sequence a hospital or clinic team can adopt.

  1. Identify risk before discharge. Flag patients with previous admissions, multiple conditions or complex medicines. Start with a simple rule your team will actually apply, such as age, diagnosis and medicines complexity.
  2. Reconcile medicines and teach back. Before the patient leaves, confirm the list and ask them to explain it in their own words.
  3. Prepare the material. Choose the education content and exercises that fit the patient's situation and agree how often they will work on them.
  4. Bridge the first 90 days. The evidence favours support that lasts, so keep in contact with the patient and add phone calls for those who need them.
  5. Hand over in writing. Follow the timings in NICE guidance for the GP and community team, and share the care plan with the carer where the patient agrees.
  6. Book targeted follow-up. Prioritise the groups where early review shows the clearest benefit.
  7. Reach out to those who drop off. Patients who stop working through their material are often the ones worth a call first.

Measuring whether it works

Track three things: 30-day emergency readmissions for your own patients, medication discrepancies found at the first follow-up contact, and how many patients work through the material they received. Break results down by age, condition and social circumstance. Chartrand and colleagues recommend future interventions attend to patients' values, preferences, age, gender, race and social determinants, and the umbrella review calls for clearer, standardised outcome measures. If one group's readmissions do not fall, change the approach for that group instead of the whole programme.

Be precise about what to expect. The best evidence is for fewer readmissions, fewer medication discrepancies and higher satisfaction. The same umbrella review rates the evidence for quality of life, emergency visits and mortality as weaker, so set your targets on the first group of outcomes.

Where SwissDTx comes in

SwissDTx is a blended-care platform that helps professionals organise the time between appointments. In the Care Cockpit, professionals put together structured content for each patient, such as education material, exercises and multimedia, and manage their patients and the content they have shared with them. Patients work through it in the Patient App at their own pace.

SwissDTx does not interpret patient information and does not suggest diagnoses or treatment decisions. Those stay entirely with the professional, as do discharge planning, medicines review and follow-up.

Licence details are on the licences page. For hospitals and clinics, our page for hospitals and clinics describes the setup, and the Patient App page shows what patients see.

FAQ

What are the most effective ways to prevent hospital readmissions?

The best-supported measures are discharge planning, medication reconciliation, patient education, and timely follow-up for higher-risk patients. Programmes that combine several of these, and that continue for weeks after discharge, show larger reductions than single actions.

What is the 30-day readmission rule?

It is a measure, not a clinical rule: it counts patients who return to hospital within 30 days of discharge. In England the NHS indicator counts emergency admissions to any hospital in that window. In the US, Medicare uses an all-cause measure and excludes planned admissions.

Which patients benefit most from follow-up after discharge?

A 2025 meta-analysis found the clearest benefit for people aged 65 and over with heart failure, heart attack, stroke or COPD. For these groups, early outpatient review combined with ongoing contact is a sensible priority.

Can digital tools help after discharge?

Digital support is associated with benefits in discharge planning for stroke and heart conditions, particularly alongside nurse-led and multidisciplinary care. Digital tools can carry education material and exercises home and keep the patient in touch with the team. The clinical assessment remains with the professionals.

How long should post-discharge support last?

The review of medication continuity found interventions that bridged the transition for up to 90 days were most effective. The right length depends on the patient's condition and risk, and is decided by the care team.

Sources

SwissDTx is Built for Blended Care

SwissDTx translates the principles of bCBT into practice. Through its Care Cockpit and Patient App, it connects people, data, and therapy into one continuous flow  — before, during, and after every session.